Profile
FEMY ISRG BDX BDXA ALC RMD
Company Name Femasys Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $25.65M $191.29B $49.98B $48.71B $43.43B $37.41B
Employees 0.07K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Ms. Kathy Lee-Sepsick M.B.A. Gary S. Guthart Mr. Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
FEMY ISRG BDX BDXA ALC RMD
Quant Rating Score 1 3 3 5 3 3
Quant Rating Strong Sell Neutral Neutral Strong Buy Neutral Neutral
Trading
FEMY ISRG BDX BDXA ALC RMD
Last Close $0.9658 $543.41 $172.25 $59.24 $88.28 $258
High 52 $1.77 $610.45 $249.08 $59.24 $100.76 $258
Low 52 $0.8 $416.14 $165.15 $59.24 $82.73 $186.94
Price vs. 52 Week High -45.44 % -10.98 % -30.85 % 0 % -12.39 % 0 %
Price vs. 52 Week Low 20.73 % 30.58 % 4.3 % 0 % 6.71 % 38.01 %
Total Return
FEMY ISRG BDX BDXA ALC RMD
1 Month Return 9.75 % -1.62 % -0.2 % 0 % 2.72 % 5.4 %
3 Month Return -21.48 % 9.48 % -23.8 % 0 % -4.77 % 16.06 %
6 Month Return -12.2 % 4.11 % -24.08 % 0 % 3.99 % 12.82 %
9 Month Return -13.77 % 12.1 % -28.73 % 0 % -10.94 % 8.06 %
YTD Return -12.2 % 4.11 % -24.08 % 0 % 3.99 % 12.82 %
1 Year Return -17.45 % 24.57 % -24.87 % 0 % 0.24 % 38.01 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
FEMY ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 2.33 % 2.38 % 0.38 % 0.83 %
Dividend Paid and Capex Coverage Ration (TTM) -22.99 % 2.77 % 1.77 % 1.77 % 4.15 % 4.21 %
Dividend Per Share (TTM) - - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) - - 76.77 % 76.77 % 11.23 % 23.14 %
Profitability
FEMY ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 66.24 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM - 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM -392.43 % 15.52 % 5.86 % 5.86 % 6.95 % 25.18 %
Return on Capital Employed TTM 201.03 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 100.03 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 106.7 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM -1164.28 % 28.2 % 11.33 % 11.33 % 15.22 % 32.1 %
Cash Flow To Debt Ratio TTM -256.21 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM - 6.46 6.89 6.89 5.35 5.53
Payables Turnover TTM 0.25 10.39 - - 5.25 9.36
Inventory Turnover TTM - 1.85 3.11 3.11 1.89 2.41
Fixed Asset Turnover TTM - 181.6 % 313.98 % 313.98 % 202.74 % 729.93 %
Asset Turnover TTM - 45.34 % 38.31 % 38.31 % 32.06 % 66.36 %
Operating Cash Flow Per Share TTM -0.78 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -0.81 4.88 8.98 8.98 3.47 10.66
Cash Per Share TTM - 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM -1155.88 % 31.34 % 15.81 % 15.81 % 21.14 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.35 % 63.9 % 78.51 % 78.51 % 81.86 % 94.64 %
Cash Flow Coverage Ratios TTM -256.21 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -1.25 109.6 19.3 18.91 25.25 23.92
Price To Operating Cash Flows Ratio TTM -1.13 69.86 15.25 14.94 20.69 22.65
Price Cash Flow Ratio TTM -1.13 69.86 15.25 14.94 20.69 22.65
Income Statement (TTM)
FEMY ISRG BDX BDXA ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 66.55% 67.46% 45.22% 45.22% 55.61% 56.67%
EBITDA $-0.02B $2.81B $4.82B $4.82B $2.68B $1.53B
Net Income $-0.02B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted -0.85 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
FEMY ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.01B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $0B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0B $6.89B $0.45B $0.45B $0.75B $0.17B
Total Debt $0.01B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.01B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
FEMY ISRG BDX BDXA ALC RMD
Net Income $-0.02B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $-0.02B $2.42B $3.8B $3.8B $2.08B $1.4B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.375
ALC Alcon Inc. 89.005
ANGO AngioDynamics, Inc. 9.79
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 158.96
ATRC AtriCure, Inc. 32.62
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 31.53
BAX Baxter International Inc. 31.06
BDX Becton, Dickinson and Company 177.17
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.505
BLFS BioLife Solutions, Inc. 21.92
COO The Cooper Companies, Inc. 72.79
DXR Daxor Corporation 9.6321
EKSO Ekso Bionics Holdings, Inc. 3.45
GCTK GlucoTrack, Inc. 6.076
ETFs With Exposure to FEMY
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 304.557
VXF Vanguard Extended Market Index Fund 0 194.515
IWC iShares Micro-Cap ETF 0.00475 129.845
DFAS Dimensional U.S. Small Cap ETF 0.00006446 64.96
VTSAX Vanguard Total Stock Market Index Fund 0 148.01
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.26
VITSX Vanguard Total Stock Market Index Fund 0 148.03
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.27
VEMPX Vanguard Extended Market Index InstlPlus 0 360.93
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 277.69
Unlock